Trial intelligence / Profile preview

Envarsus XR with Early Steroid Withdrawal in Kidney Transplant

NCT03828682Phase 4Unknown

Start
Jun 2019
Primary completion
Jul 2021
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus in kidney transplant rejection. Status: unknown.

02

Drugs

tacrolimus
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT03828682.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03828682.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call